CIDNAVIR 75MG/ML INJ

CIDNAVIR 75MG/ML INJ is an antiviral medicine used in the treatment of cytomegalovirus (CMV) retinitis. Cytomegalovirus (CMV) retinitis is a viral infection that affects the retina of the eye caused by a virus called Cytomegalovirus (CMV), especially in AIDS patients. It is a serious infection that can lead to blindness. CIDNAVIR 75MG/ML INJ is used in combination with oral probenecid.

CIDNAVIR 75MG/ML INJ contains Cidofovir, which works by inhibiting the CMV polymerase enzyme responsible for viral DNA synthesis. It works by slowing the growth of the cytomegalovirus. Thus, it helps treat Cytomegalovirus (CMV) retinitis.

CIDNAVIR 75MG/ML INJ may cause certain side effects such as nausea, vomiting, headache, hair loss, rash, weakness, fever, inflammation of the eye, shortness of breath, diarrhoea, chills, and pain at the injection site. These side effects may not occur in every patient using this medication and gradually resolve over time. If the side effects persist longer or worsen, please inform your doctor. A healthcare professional will administer CIDNAVIR 75MG/ML INJ; hence, do not self-administer.

CIDNAVIR 75MG/ML INJ should be avoided if you are allergic to it. This medicine is contraindicated in patients with renal insufficiency and patients who cannot receive probenecid or other sulfa-containing products. This medicine should not be used for conditions other than CMV retinitis. Let your doctor know about your complete medical and medication history to rule out any interactions. Inform your doctor if you have a weakened immune system, an electrolyte imbalance, diabetes, and liver or kidney diseases before starting the use of CIDNAVIR 75MG/ML INJ. CIDNAVIR 75MG/ML INJ is not recommended for use in pregnant and breastfeeding women.

CIDNAVIR 75MG/ML INJ treats viral infection of the eye caused by Cytomegalovirus (CMV) retinitis. CIDNAVIR 75MG/ML INJ consists of Cidofovir, which works by inhibiting the CMV polymerase enzyme responsible for viral DNA synthesis. It helps kill the virus and eventually stop the growth of the cytomegalovirus. Thus, helps to treat Cytomegalovirus (CMV) retinitis. This medicine is only used in treating CMV retinitis but is not used for other conditions. It does not help in treating HIV infection.

CIDNAVIR 75MG/ML INJ should be avoided if you are allergic to it. Let your doctor know about your medical history and medication history to rule out any interactions. This medicine is contraindicated in patients with renal insufficiency, patients who cannot receive probenecid or other sulfa-containing products, and the use of CIDNAVIR 75MG/ML INJ in conditions other than CMV retinitis. Inform your doctor if you have a weakened immune system, an electrolyte imbalance, diabetes, and liver or kidney diseases before starting CIDNAVIR 75MG/ML INJ. CIDNAVIR 75MG/ML INJ is not recommended for use in pregnant and breastfeeding women. Hence, inform your doctor before starting CIDNAVIR 75MG/ML INJ.  CIDNAVIR 75MG/ML INJ may cause nephrotoxicity, haematological toxicity, decreased intraocular pressure, and metabolic acidosis in some patients. Hence, patients should be monitored carefully for any changes during the treatment. CIDNAVIR 75MG/ML INJ is not recommended for use in children below 16 years of age as the safety and efficacy are not established. Avoid driving and operating machines, as it can cause fatigue and dizziness.

• CIDNAVIR 75MG/ML INJ is administered only by intravenous route. Direct intraocular injection is not recommended as it can cause visual impairment.
• Frequent eye tests and regular kidney function tests will be advised to check for any changes.
• CIDNAVIR 75MG/ML INJ should not be administered in patients who are unable to take probenecid or other sulpha-containing medicines.